Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice

• Published in: Molecular pharmacology 2004-08, Vol.66 (2), p.204-208
• Main Authors: Jin, Kunlin, Xie, Lin, Kim, Sun Hee, Parmentier-Batteur, Sophie, Sun, Yunjuan, Mao, Xiao Ou, Childs, Jocelyn, Greenberg, David A
• Format: Article
• Language: English
• Subjects: Animals; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons - physiology; Receptor, Cannabinoid, CB1 - deficiency; Receptor, Cannabinoid, CB1 - genetics; Receptor, Cannabinoid, CB1 - physiology
• ISSN: 0026-895X; 1521-0111
• DOI: 10.1124/mol.66.2.204

Pharmacological studies suggest a role for CB1 cannabinoid receptors (CB1R) in regulating neurogenesis in the adult brain. To investigate this possibility, we measured neurogenesis by intraperitoneal injection of bromodeoxyuridine (BrdU), which labels newborn neurons, in wild-type and CB1R-knockout (CB1R-KO) mice. CB1R-KO mice showed reductions in the number of BrdU-labeled cells to ∼50% of wild-type (WT) levels in dentate gyrus and subventricular zone (SVZ), suggesting that CB1R activation promotes neurogenesis. To test this further, WT mice were given the CB1R antagonist N -(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1 H -pyrazole-3-carboximide hydrochloride (SR141716A) before measuring neurogenesis with BrdU. SR141716A paradoxically increased the number of BrdU-labeled cells by ∼50% in SVZ; another CB1R antagonist, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl- N -1-piperidinyl-1 H -pyrazole-3-carboxamide (AM251), had a similar effect. To investigate this discrepancy, SR141716A was given to CB1R-KO mice, in which it still stimulated neurogenesis, indicating involvement of a non-CB1 receptor. Action at one such non-CB1, SR141716A-sensitive site, the VR1 vanilloid receptor, was tested by administering SR141716A to VR1-KO mice, in which the ability of SR141716A to enhance neurogenesis was abolished. Thus, CB1 and VR1 receptors both seem to have roles in regulating adult neurogenesis.